Author:
Li Jingxi,Li Xue,Wu Keheng,Long Sihui,Zhao Youni,Jin Xiong,Zhang Mengjun,Wu Xinyi,Huang Zhijun,Zhou Zhou,Liu Jack,Liu Bo
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Peltoniemi MA, Saari TI, Hagelberg NM, Laine K, Kurkinen KJ, Neuvonen PJ, Olkkola KT. Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine. Basic Clin Pharmacol Toxicol. 2012;111(5):325–32.
2. Li X, Wu K, Zhou Z, Jia R, Zhao Y, Li J, et al. Predicting fluconazole drug-drug interactions using a physiologically based pharmacokinetic (PBPK) model. J Infect Dis Ther. 2022;10(4):1000504. Availability at: https://www.omicsonline.org/open-access-pdfs/predicting-fluconazole-drugdrug-interactions-using-a-physiologicallybased-pharmacokinetic-pbpk-model.pdf
3. Zhang F, Zhou Y, Wu N, Jia R, Liu A, Liu B, Zhou Z, Hu H, Han Z, Ye X. In silico prediction of bioequivalence of Isosorbide Mononitrate tablets with different dissolution profiles using PBPK modeling and simulation. Eur J Pharm Sci. 2021;157:0928–87.
4. Kato M, Shitara Y, Sato H, Yoshisue K, Hirano M, Ikeda T, Sugiyama Y. The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling. Pharm Res. 2008;25(8):1891–901.
5. Kato M, Chiba K, Horikawa M, Sugiyama Y. The quantitative prediction of in vivo enzyme-induction caused by drug exposure from in vitro information on human hepatocytes. Drug Metab Pharmacokinet. 2005;20(4):236–43.